FDA (6,900 employees, $6.5B budget) regulates 20% of US consumer spending across drugs, devices, and food. In April 2026, accelerated trial transparency enforcement and approved 12+ novel therapies including first FSGS drug, gene therapy for leukocyte adhesion deficiency, and genome editing guidance.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.